T1	Participants 55 123	NPM1 mutated, but not in NPM1 unmutated, AML with a normal karyotype
T2	Participants 201 243	patients with acute myeloid leukemia (AML)
T3	Participants 305 343	648 normal karyotype (NK) AML patients
T4	Participants 530 575	329 patients with a mutated NPM1 gene (NPM1+)
T5	Participants 588 633	319 patients without a NPM1 mutation (wtNPM1)
T6	Participants 820 834	NPM1+ subgroup
T7	Participants 1060 1076	NPM1-mutated AML
